Skip to main navigation
Alimera Sciences
  • Areas of Focus
    • Diabetic Retinopathy
    • Diabetic Macular Edema (DME)
    • Retinal Vein Occlusion (RVO)
    • Age-Related Macular Degeneration (AMD)
  • Products Overview
    • ILUVIEN® for DME
    • NADPH Oxidase Inhibitors
    • Full Prescribing Information
    • ILUVIEN® Patent Notices
  • Investor Relations
    • Investor Overview
    • Events & Presentation
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor FAQs
    • Contact Investor Relations
  • News
  • About Us
    • Management Team
    • Board of Directors
    • Careers
    • Contact Us
    • Compliance Program
  • Ophthalmic Meetings

Investor Relations

  • Investor Relations
  • Events & Presentations
  • Corporate Governance
  • Financial Information
  • Stock Information
  • Investor FAQs
  • Contact Investor Relations
A A A

1Q 2017 Earnings Conference Call

1Q 2017 Earnings Conference Call

May 9, 2017 at 8:00 AM EDT

Listen to webcast

Stock Quote

  •  
  • Apr 12, 20193:20 AM EDT
  • Quotes delayed at least 20 min., by Nasdaq.
  • Intra
  • 3 mo.
  • 6 mo.
  • 1 yr.
Intraday stock price graph
3 month stock price graph
6 month stock price graph
12 month stock price graph

Shareholder Tools
  • © 2019 Alimera Sciences. This site intended for US residents only.
  • Legal Statement
  • Privacy Policy
  • Privacy Shield Policy
  • Contact Us
  • Follow us on
  • Facebook
  • Twitter
  • You Tube
  • RSS